# Visible Light Study

> **NCT02663921** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 8 (actual)

## Conditions studied

- Skin Disease
- Pigment Disorders

## Interventions

- **OTHER:** Part A: Baseline-Week 2
- **OTHER:** Part B: Week 4-Week 12

## Key facts

- **NCT ID:** NCT02663921
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-04-17
- **Final completion:** 2019-04-17
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663921, "Visible Light Study". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT02663921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*